Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women

Por Nahuis, Marleen, van der Veen, Fulco, Oosterhuis, Jur, Mol, Ben Willem, Hompes, Peter, van Wely, Madelon
Publicado em 2010

The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving...

Por Nahuis, Marleen J, Weiss, Nienke S, van der Veen, Fulco, Mol, Ben Willem J, Hompes, Peter G, Oosterhuis, Jur, Lambalk, Nils B, Smeenk, Jesper MJ, Koks, Carolien AM, van Golde, Ron JT, Laven, Joop SE, Cohlen, Ben J, Fleischer, Kathrin, Goverde, Angelique J, Gerards, Marie H, Klijn, Nicole F, Nekrui, Lizka CM, van Rooij, Ilse AJ, Hoozemans, Diederik A, van Wely, Madelon
Publicado em 2013